Literature DB >> 25304067

Lowering furosemide dose in stable chronic heart failure patients with reduced ejection fraction is not accompanied by decompensation: a randomized study.

Chris J Kapelios1, Elisabeth Kaldara1, Argyrios Ntalianis1, Emmeleia Nana1, Chris Pantsios1, Evangelos Repasos1, Zafeiria Margari1, Vasileios Sousonis1, Konstantinos Malliaras1, John N Nanas2.   

Abstract

Entities:  

Keywords:  Chronic heart failure; Diuretics; Mortality; Prognosis; Risk factor

Mesh：

Substances：

Year:  2014        PMID： 25304067     DOI： 10.1016/j.ijcard.2014.09.156

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN： 0167-5273            Impact factor:   4.164


× No keyword cloud information.
  5 in total

Review 1.  Impact of Loop Diuretic on Outcomes in Patients with Heart Failure and Reduced Ejection Fraction.

Authors:  Cicoira Maria Antonietta; Emiliano Calvi; Andrea Faggiano; Caterina Maffeis; Marco Bosisio; Marco De Stefano; Stefano Carugo; Pompilio Faggiano
Journal:  Curr Heart Fail Rep       Date:  2022-01-17

2.  Clinical predictors of hyponatremia in patients with heart failure according to severity of chronic kidney disease.

Authors:  Ivan Velat; Željko Bušić; Viktor Čulić
Journal:  Wien Klin Wochenschr       Date:  2022-05-17       Impact factor: 2.275

Review 3.  Angiotensin Receptor Neprilysin Inhibitors in HFrEF: Is This the First Disease Modifying Therapy Drug Class Leading to a Substantial Reduction in Diuretic Need?

Authors:  Brian Kerr; Rebabonye B Pharithi; Matthew Barrett; Carmel Halley; Joe Gallagher; Mark Ledwidge; Kenneth McDonald
Journal:  Int J Heart Fail       Date:  2021-02-25

Review 4.  Association of loop diuretics use and dose with outcomes in outpatients with heart failure: a systematic review and meta-analysis of observational studies involving 96,959 patients.

Authors:  Chris J Kapelios; Μaria Bonou; Konstantinos Malliaras; Eleni Athanasiadi; Styliani Vakrou; Marina Skouloudi; Constantina Masoura; John Barbetseas
Journal:  Heart Fail Rev       Date:  2022-01       Impact factor: 4.214

5.  Furosemide and spironolactone doses and hyponatremia in patients with heart failure.

Authors:  Ivan Velat; Željko Bušić; Marina Jurić Paić; Viktor Čulić
Journal:  BMC Pharmacol Toxicol       Date:  2020-08-03       Impact factor: 2.483
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.